NW
GMAB icon

NewEdge Wealth’s Genmab GMAB Stock Holding History

NewEdge Wealth’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$365K Sell
13,271
-530
-4% -$14.1K ﹤0.01% 966
2026
Q1 		$370K Buy
13,801
+306
+2% +$9.17K ﹤0.01% 908
2025
Q4 		$416K Buy
13,495
+1,635
+14% +$51K ﹤0.01% 906
2025
Q3 		$346K Buy
+11,860
New +$289K 0.01% 840
2025
Q2 		– Sell
-57,353
Closed -$1.12M – 990
2025
Q1 		$1.12M Buy
57,353
+9,283
+19% +$195K 0.02% 452
2024
Q4 		$1M Sell
48,070
-72,663
-60% -$1.6M 0.02% 482
2024
Q3 		$2.94M Buy
120,733
+8,294
+7% +$222K 0.05% 295
2024
Q2 		$2.83M Buy
112,439
+11,832
+12% +$335K 0.06% 260
2024
Q1 		$2.79M Sell
100,607
-19,382
-16% -$569K 0.06% 263
2023
Q4 		$3.82M Buy
119,989
+40,382
+51% +$1.27M 0.1% 177
2023
Q3 		$2.81M Buy
79,607
+17,521
+28% +$668K 0.09% 197
2023
Q2 		$2.36M Buy
62,086
+15,234
+33% +$607K 0.08% 222
2023
Q1 		$1.77M Buy
46,852
+20,836
+80% +$801K 0.07% 244
2022
Q4 		$1.1M Sell
26,016
-4,350
-14% -$179K 0.05% 280
2022
Q3 		$976K Buy
30,366
+4,305
+17% +$151K 0.05% 275
2022
Q2 		$847K Buy
26,061
+20,392
+360% +$661K 0.04% 307
2022
Q1 		$205K Sell
5,669
-172
-3% -$5.9K 0.01% 401
2021
Q4 		$231K Sell
5,841
-183
-3% -$7.63K 0.01% 370
2021
Q3 		$263K Buy
6,024
+778
+15% +$34.9K 0.02% 256
2021
Q2 		$214K Buy
+5,246
New +$202K 0.02% 268

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

NewEdge Wealth's GMAB Position: Q2 2026 in Review

NewEdge Wealth reduced its Genmab (GMAB) stake by 3.8% in Q2 2026, selling an estimated $14.1K and leaving 13,271 shares worth $365K. The position accounts for ﹤0.01% of the portfolio, ranked #966.

NewEdge Wealth first reported a position in GMAB in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.82M in Q4 2023. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • NewEdge Wealth held 13,271 shares of Genmab worth $365K as of Q2 2026.
  • NewEdge Wealth sold 530 Genmab shares in Q2 2026, an estimated $14.1K.
  • Genmab made up ﹤0.01% of NewEdge Wealth's portfolio in Q2 2026, its #966 holding.
  • NewEdge Wealth first reported a position in Genmab in Q2 2021 and has held it in 20 quarters since.
  • NewEdge Wealth's Genmab position peaked at $3.82M in Q4 2023.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.